Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
45.92
+1.15 (2.57%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $2.70 billion as of September 19, 2024. Its market cap has increased by 140.24% in one year.
Market Cap
2.70B
Enterprise Value
2.05B
1-Year Change
140.24%
Ranking
Category
Stock Price
$45.92
Market Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $2.70B, an increase of 1,477.20%. That is a compound annual growth rate of 40.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2024 | 2.64B | 99.40% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 2.72B |
| ACADIA Pharmaceuticals | 2.71B |
| Amneal Pharmaceuticals | 2.70B |
| 10x Genomics | 2.66B |
| SpringWorks Therapeutics | 2.64B |
| UFP Technologies | 2.59B |
| Veracyte | 2.59B |
| Agios Pharmaceuticals | 2.59B |